NRSA Training Core

NRSA 培训核心

• 批准号: 9330217
• 负责人: TIMOTHY De Ver DYE
• 金额: $ 51.73万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-15 至 2020-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9330217
• 关键词: Academic support; Address; Area; Award; Big Data; Bioinformatics; Biological Markers; Clinical; Clinical Research; Clinical Sciences; Communities; Creativeness; Data Analytics; Data Science; Development; Discipline; Doctor of Philosophy; Electronic Health Record; Evaluation; Evidence based practice; Fellowship; Genotype; Goals; Health Care Reform; Healthcare; Infection; Institutes; Institution; Interdisciplinary Study; Learning; Link; Medical; Medical Education; Mentors; Methodology; Methods; Minority-Serving Institution; Modeling; National Research Service Awards; Phenotype; Physicians; Population; Postdoctoral Fellow; Recording of previous events; Research; Research Personnel; Research Training; Role; Science; Scientist; Structure; Students; TNFSF15 gene; Training; Training Programs; Training Support; Translational Research; Universities; Vision; base; biopsychosocial; clinical development; education research; experience; flexibility; health care delivery; improved; innovation; multidisciplinary; novel; personalized medicine; population health; pre-doctoral; precision medicine; programs; research and development; tool; training opportunity; translational scientist

The University of Rochester (UR) has a decades-long distinguished history in innovative clinical research education, enhanced substantially since 2006 with the establishment and focus of the University of Rochester Clinical and Translational Science Institute (UR-CTSI). Building historically on the groundbreaking concept of medical education based on the biopsychosocial model starting in the 1940s with Engel and Romano, the UR has continued to create paradigm-shifting educational reform integrating research and systematic evaluation with problem-based medical education, community engagement and population health, and mentored field experience. This culture of creativity and innovation in pre-doctoral research training supported through prior TL1 awards is embodied by an institutional focus on research training from molecules to populations. Through this and other means, the UR-CTSI has created an institution-wide focal point for multidisciplinary research training. Further, UR-TL1-supported students in the 50+ year-old UR MD/PhD training program (Medical Scientist Training Program (MSTP)) have taken advantage of the UR-CTSI's PhD program in Translational Biomedical Science and other multidisciplinary graduate training options. In addition, the UR-TL1-supported Academic Research Track (ART) further provides a pipeline of clinical and translational research-prepared academic physicians through a comprehensive research training and mentoring experience. Predoctoral training is a priority within Rochester's CTSI, is well-integrated, and has successfully generated productive, employed clinical researchers, both within and outside of academics. The vision for the UR-TL1 in the next era of UR-CTSI is inspired by several critical developments in the healthcare and institutional landscape of Rochester and the US more broadly, namely: 1) Implementation of national health care reform prioritizing evidence-based practice and population health, 2) rapid emergence of data science and “Big Data” analytic opportunities and methodological approaches to healthcare and population health, and 3) emergence of precision medicine research and healthcare delivery using phenotype- genotype and biomarker-informed science. The goals for the coming five years include 1) to grow a pipeline of clinical and translational researchers able to address new and emerging scientific and methodological domains; 2) to enhance experiential and didactic learning through new training opportunities and partnerships that emphasize team science; 3) to stimulate creative and novel population health research that involves leveraging new tools and methods through establishing a University-wide Post-Doctoral Fellowship in Population Health; and 4) to rigorously evaluate the role of the UR-TL1 Training Program on the development of the clinical and translational research pipeline and disseminate learnings from the training program.

罗切斯特大学（UR）在创新临床研究方面有着数十年的杰出历史 教育，自2006年以来，随着罗切斯特大学的建立和重点， 临床和转化科学研究所（UR-CTSI）。历史性地建立在突破性的概念上， 基于生物心理社会模型的医学教育始于20世纪40年代，由恩格尔和罗马诺，UR 继续进行整合研究和系统评估的范式转变教育改革 以问题为基础的医学教育，社区参与和人口健康， 体验.这种创造力和创新的文化，在博士前的研究培训支持，通过事先 TL 1奖项体现在机构对从分子到群体的研究培训的关注。通过 通过这种方式和其他方式，UR-CTSI已经为多学科研究建立了一个全机构的联络点 训练此外，UR-TL 1支持的学生在50+岁的UR MD/博士培训计划（医学 科学家培训计划（MSTP））利用UR-CTSI的翻译博士课程 生物医学科学和其他多学科研究生培训选项。此外，UR-TL 1支持 学术研究轨道（ART）进一步提供了临床和转化研究准备的管道 通过全面的研究培训和指导经验，学术医生。博士前 培训是罗切斯特CTSI的优先事项，整合良好，并成功地产生了生产力， 聘请了临床研究人员，包括学术界内外的研究人员。 UR-TL 1在UR-CTSI下一个时代的愿景受到了几个关键发展的启发， 罗切斯特和美国更广泛的医疗保健和机构格局，即：1）实施 国家卫生保健改革优先重视循证实践和人口健康，2） 数据科学和“大数据”分析机会以及医疗保健和 人口健康，以及3）精准医学研究和使用表型的医疗保健服务的出现- 基因型和生物标志物的科学。未来五年的目标包括：1）发展一个 临床和翻译研究人员能够解决新的和新兴的科学和方法 2）通过新的培训机会和伙伴关系加强经验和教学学习 强调团队科学; 3）鼓励创造性和新颖的人口健康研究， 利用新的工具和方法，通过建立一个大学范围内的博士后奖学金，在 人口健康;以及4）严格评估UR-TL 1培训计划在发展 临床和转化研究管道和传播学习的培训计划。